LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Journal of Cell Biology

Volumn 144, Issue 4, 1999, Pages 789-801

  Banerji, Suneale ^a   Ni, Jian ^d   Wang, Shu Xia ^d   Clasper, Steven ^a   Su, Jeffrey ^d   Tammi, Raija ^c   Jones, Margaret ^b   Jackson, David G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d GLAXOSMITHKLINE   (United States)

Author keywords

DNA, complementary; Endothelium, lymphatic; Hyaluronic acid; Receptors, cell surface; Recombinant fusion proteins

Indexed keywords

GLYCOPROTEIN; HYALURONIC ACID;

ARTICLE; HUMAN; HUMAN CELL; LYMPH VESSEL; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; BASE SEQUENCE; CELL MEMBRANE; CELLS, CULTURED; CLONING, MOLECULAR; COS CELLS; DNA PRIMERS; DNA, COMPLEMENTARY; GLYCOPROTEINS; HUMANS; HYALURONIC ACID; LYMPHATIC SYSTEM; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 0033593793     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.144.4.789     Document Type: Article

References (61)

1. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underbill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1303-1313.
2. Bajorath, J., B. Greenfield, S.B. Munro, A.J. Day, and A. Aruffo. 1998. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J. Biol, Chem. 273:338-343.
3. Banerji, S., A.J. Day, J.D. Kahmann, and D.G. Jackson. 1998. Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli. Protein Exp. Purification. 14:371-381.
4. Bennett, K., D.O. Jackson, J.C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamenkovic, G. Plowman, and A. Aruffo. 1995. CD44 isoforms containing exon v3 are responsible for the presentation of heparin binding growth factor. J. Cell Biol. 128:687-598.
5. Bennett, K., B. Modrell, B. Greenfield, A. Bartolazzi, I. Stamenkovic, R. Peach, D. Jackson, F. Spring, and A. Aruffo. 1995. Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 131:1623-1633.
6. Clark, R.A., R. Alon, and T.A. Springer. 1996. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol. 134:1075-1087.
7. De Grendele, H.C., P. Estess, L.J. Picker, and M.H. Siegelman. 1996. CD44 and its ligand hyaluronate mediate rolling under physiological flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183:1119-1130.
8. De Grendele, H.C., P. Estess, and M.H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 278:672-675.
9. Doege, K.J., M. Sasaki, T. Kimura, and Y. Yamada. 1991. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. J. Biol. Chem. 266:894-902.
10. Engstrom-Laurent, A. 1989. Changes in hyaluronan concentration in tissues and body fluids in disease states. CIBA Found. Symp. 143:233-247.
11. Fraser, J.R., and T.C. Laurent. 1989. Turnover and metabolism of hyaluronan. CIBA Found. Symp. 143:41-53.
12. Fraser, J.R., W.G. Kimpton, T.C Laurent, R.N. Cahill, and N. Vakakis. 1988. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem. J. 256:153-158.
13. Goldstein, L.A., D.F. Zhou, L.J. Picker, C.N. Mirty, R.F. Bargatze, J.F. Ding, and E.C. Butcher. 1989. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell. 56:1063-1072.
14. Grammatikakis, N., A. Grammatikakis, M. Yoneda, O. Yu, S.D. Banerjee, and B.P. Toole. 1995. A novel glycosaminoglycan-binding protein is the vertebrate homologue of the cell cycle control protein. Cdc37. J. Biol. Chem. 270:16198-16205.
15. Hardwick, C., K. Hoare, R. Owens, H.P. Hohn, M. Hook, D. Moore, V Cripps, L. Austen, D.M. Nance, and E.A. Turley. 1992. Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J. Cell Biol. 117:1343-1350.
16. Isacke, C.M. 1994. The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 107:2353-2359.
17. Jackson, D.G., J.I. Bell, R. Dickinson, J. Timans, J. Shields, and N. Whittle. 1995. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol. 128: 673-686.
18. Knudson, C.B. 1993. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J. Cell Biol. 120:825-834.
19. Knudson, C.B., and W. Knudson. 1993. Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB (Fed. Am. Soc. Exp. Biol.) J. 7:1233-1241.
20. Knudson, W., and C.B. Knudson. 1991. Assembly of a chondrocyle-like pericellular matrix on non-chondrogenic cells. J. Cell Sci. 99:227-235.
21. Knudson, W., C. Biswas, X.Q. Li, R.E. Nemec, and B.P. Toole. 1989. The role and regulation of tumour-associated hyaluronan. CIBA Found. Symp. 143:150-169.
22. Knudson, W., E. Bartnik, and C.B. Knudson. 1993. Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc. Natl. Acad. Sci. USA. 90:4003-4007.
23. Kohda, D., C.J. Morton, A.A. Parkar, H. Hatanaka, P.M. Inagaki, I.D. Campbell, and A.J. Day. 1996. Solution structure of the link module: a hyaluronan binding domain involved in extracellular matrix stability and cell migration. Cell. 86:767-775.
24. Kozak, M. 1984. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucl. Adds Res. 12:857-872.
25. Kyte, J., and R.F. Doolittle. 1982. A simple method for displaying the hydrophobic character of a protein. J Mol. Biol. 157:105-132.
26. Laurent, T.C., and J.R. Fraser. 1992. Hyaluronan. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6:2397-2404.
27. Lebel, L., L. Smith, B. Risberg, T.C. Laurent, and B. Gerdin. 1989. Increased lymphatic elimination of interstitial hyaluronan during E. coli sepsis in sheep. Am. J. Physiol. 256:1524-1531.
28. Lee, T.H., H.G. Wismewski, and J. Vilcek. 1992. A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44. J. Cell Biol. 116:545-557.
29. Lesley, J., R. Hyman, and P.W. Kincade. 1994. CD44 and its interaction with the extracellular matrix. Adv. Immunol. 54:271-335.
30. Liu, D., and M.S. Sy. 1996. A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J. Exp. Med. 183:1987-1994.
31. McDonald, J.A., T. Brehmgibson, T. Cananisch, and A.P. Spicer. 1998. Molecular cloning and gene targeting of hyaluronan synthase 2 reveals a critical role in the development of the cardiovascular system in the mouse. Glycobiology. 8:146-155.
32. Miettinen, M., A.E. Lindenmayer, and A. Chaubal. 1994. Endothelial cell markers CD31, CD34, and BNH9 antibody to H-and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod. Pathol. 7:82-90.
33. Mikecz, K., F.R. Brennan, J.H. Kim, and T.T. Glant. 1995. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis. Nat. Med. 1:558-563.
34. Neame, P.J., J.E. Christner, and J.R. Baker. 1986. The primary structure of Link protein from rat chondrosarcoma proteoglycan aggregate. J. Biol. Chem. 261:3519-3535.
35. Neame, S.J., C.R. Uff, H. Sheikh, S.C. Wheatley, and C.M. Isacke. 1995. CD44 exhibits a cell type dependent interaction with Triton X-100 insoluble, lipid rich, plasma membrane domains. J. Cell Sci. 108:3127-3135.
36. Ostgaard, G., and R.K. Reed. 1993. Intravenous saline infusion in rat increases hyaluronan efflux in intestinal lymph by increasing lymph flow. Acta. Physiol. Scand. 147:329-335.
37. Peach, R.J., D. Hollenbaugh, I. Stamenkovic, and A. Aruffo. 1993. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:257-264.
38. Peck, D., and C.M. Isacke. 1996. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Curr. Biol. 6:884-890.
39. Perschl, A., J. Lesley, N. English, R. Hyman, and I.S. Trowbridge. 1995. Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J. Cell Sci. 108:1033-1041.
40. Picker, L.J., J. De los Toyos, M.J. Telen, B.F. Haynes, and E.C. Butcher. 1989. Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J. Immunol. 142:2046-2051.
41. Picker, L.J., M. Nakache, and E.C. Butcher. 1989. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J. Cell Biol. 109:927-937.
42. Sauter, B., D. Foedinger, B. Sterniczky, K. Wolff, and K. Rappersberger. 1998. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs. blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J. Histochem. Cytochem. 46:165-176.
43. Schmits, R., J. Filmus, N. Gerwin, G. Senaldi, F. Kiefer, T. Kundig, A. Wakeham, A. Shahinian, C. Catzavelos, J. Rak, et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicily. Blood. 90:2217-2233.
44. Sleeman, J., W. Rudy, M. Hofmann, J. Moll, P. Herrlich, and H. Ponta. 1996. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol. 135:1139-1150.
45. Stamenkovic, I., M. Amiot, J.M. Pesando, and B. Seed. 1989. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell. 56:1057-1062.
46. Sy, M.S., Y.J. Guo, and I. Stamenkovic. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174:859-866.
47. Sy. M.S., Y.J. Guo, and I. Stamenkovic. 1992. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J. Exp. Med. 176:623-627.
48. Tammi, R., U.M. Ågren, A.-L. Tuhkanen, and M. Tammi. 1994. Hyaluronan metabolism in skin. Progress Histochem. Cytochem. 29:1-77.
49. Tengblad, A., U.B. Laurent, K. Lilja, R.N. Cahill, A. Engstrom-Laurent, J.R. Fraser, H.E. Hansson, and T.C. Laurent. 1986. Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem. J. 236:521-525.
50. Thomas, L., H.R. Byers, J. Vink, and I. Stamenkovic. 1992. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118:971-977.
51. Toole, B.P. 1990. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 2:839-844.
52. Tsukita, S., K. Oishi, N. Sato, J. Sagara, A. Kawai, and S. Tsukita. 1994. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:391-401.
53. Turley, E.A., L. Austen, D. Moore, and K. Hoare. 1993. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp. Cell Res 207:277-282.
54. Tzaicos, C., J.R. Fraser, E. Tsotsis, and W.G. Kimpton. 1989. Inhibition of hyaluronan uptake in lymphatic tissue by chondroitin sulphate protcoglycan. Biochem. J. 264:823-828.
55. Underbill, C.B., G. Chi-Rosso, and B.P. Toole. 1983. Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40-transformed 3T3 cells. J. Biol. Chem. 258:8086-8091.
56. Von Heijne, G. 1984. How signal sequences maintain cleavage specificity. J. Mol. Biol. 173:243-251.
57. Weiss, J.M., J. Sleeman, A.C. Renkl, H. Dittmar, C.C. Termeer, S. Taxis, N. Howells, M. Hofmann, G. Kohler, E. Schopf, et al. 1997. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1137-1147.
58. Yamada, H., K. Watanabe, M. Shimonaka, and Y. Yamaguchi. 1994. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/ versican family. J. Biol. Chem. 269:10119-10126.
59. Yannariello-Brown, J., S.J. Frost, and P.H. Weigel. 1992. Identification of the Ca(2+)-independent endocytic hyaluronan receptor in rat liver sinusoidal endothelial cells using a photoaffinit cross-linking reagent. J. Biol. Chem. 267:20451-20456.
60. 2+-dependent hyaluronan binding activity. J. Cell Biochem. 48:73-80.
61. Zimmerman, D.R., and E. Ruoslahti. 1989. Multiple domains of the large fibroblast proteoglycan versican. EMBO (Eur. Mol. Biol. Organ.) J. 8:2975-2981.